Impact of chronic coffee consumption on critical illness during intensive care treatment

Impact of chronic coffee consumption on critical illness during intensive care treatment - CritCoff

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00026902

Enrollment

360

Registered

2021-10-13

Start date

2022-01-20

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intestinal function during critical illnes

Interventions

Group 1: Patients with chronic coffee consumption are examined in the first four days of critical illness with organ failure with regard to intestinal function and hemodynamics. Group 2: Patients with

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Admission to the ICU within the last 12 hours Existing critical illness, defined by the presence of at least one of the following parameters of organ failure: AKIN II Norepinephrine> 0.05 µg / kg body weight / min GCS 10 qSOFA> 1

Exclusion criteria

Exclusion criteria: • Pregnant / breastfeeding patients • Palliative treatment goal • Known bowel dysfunction

Design outcomes

Primary

Measure	Time frame
Time to first defecation during intensive care therapy	—

Secondary

Measure	Time frame
• Time to first bowel movement during intensive care therapy • hemodynamic target parameterschange in blood pressure, heart rate and oxygen saturation • Ventilation settings in the case of invasive ventilation as well as parameters of respiration and oxygen supply • Differences in gastric residual volume (GRV) • Differences in abdominal ultrasound (AGUIS, GUTS score) • Differences in routine laboratory controls and inflammatory markers during intensive care treatment • Duration of intensive care treatment / hospital treatment • Frequency of newly occurring organ dysfunctions during intensive care therapy based on the target parameters defined as inclusion criteria.	—

Measure

Time frame

• Time to first bowel movement during intensive care therapy • hemodynamic target parameterschange in blood pressure, heart rate and oxygen saturation • Ventilation settings in the case of invasive ventilation as well as parameters of respiration and oxygen supply • Differences in gastric residual volume (GRV) • Differences in abdominal ultrasound (AGUIS, GUTS score) • Differences in routine laboratory controls and inflammatory markers during intensive care treatment • Duration of intensive care treatment / hospital treatment • Frequency of newly occurring organ dysfunctions during intensive care therapy based on the target parameters defined as inclusion criteria.

—

Countries

Germany

Contacts

Public ContactSascha Treskatsch

Charité Universitätsmedizin Berlin

sascha.treskatsch@charite.de004930450551522

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026